DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for paranasal sinus disease — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleParanasal sinus disease maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for paranasal sinus disease is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
interleukin 33 (IL33) — IL33 is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet apo structuredrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 4KC3 · 3.2702 Å · ligand none (apo structure). Experimental structure, not a prediction.
What the evidence adds up to
Sinusitis is an inflammation of the paranasal sinuses and is one of the most common diseases worldwide. Its cause involves a complex interaction of environmental, genetic and infectious factors. The condition is usually perpetuated by pathogenic bacteria, and management typically includes both pharmacological and non-pharmacological approaches. A 2024 literature review synthesises recent studies on the contribution of pathogenic bacteria to sinusitis and highlights treatment and therapeutic strategies.
The review does not report any original clinical data, survival figures, response rates or sample sizes. It identifies interrelations between different microbial populations and host factors as gaps that require future research. No specific drug, antibiotic or repurposed compound is named in the abstract.
What is still missing is any original trial testing a specific drug for sinusitis, any quantitative evidence of treatment outcomes, and any patient stratification that might link microbial profiles to therapy. The review itself calls for a complete understanding of the microbial landscape before proper regimens can be developed, meaning the evidence base for any particular drug remains absent.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Zenodo (CERN European Organization for Nuclear Research) · 2024 · 0 citations · open access
Pathogenic Bacteria Associated with Sinusitis: A Review Article
AbstractThe sinusitis, an inflammation of paranasal sinuses, is one of the most common diseases that affect many individuals all over the world. The etiology and epidemiology of sinusitis result from complex multifactor interaction of environmental, genetic and infectious factors. Management typically involves both pharmacological and non-pharmacological means. The rationale being, sinusitis, an inflammation of the sinus cavities, is usually a disorder perpetuated by pathogenic bacteria. It is critical to have a complete understanding of the microbial landscape associated with the disease to develop proper therapeutic regimens. In this literature review, recent studies are synthesized about the contribution of pathogenic bacteria to sinusitis, wherein interrelations between different microbial populations and host factors are also proposed as gaps for future research. In addition, treatment and therapeutic strategies have been also highlighted.
Zenodo (CERN European Organization for Nuclear Research) · 2024 · 0 citations · open access
Pathogenic Bacteria Associated with Sinusitis: A Review Article
AbstractThe sinusitis, an inflammation of paranasal sinuses, is one of the most common diseases that affect many individuals all over the world. The etiology and epidemiology of sinusitis result from complex multifactor interaction of environmental, genetic and infectious factors. Management typically involves both pharmacological and non-pharmacological means. The rationale being, sinusitis, an inflammation of the sinus cavities, is usually a disorder perpetuated by pathogenic bacteria. It is critical to have a complete understanding of the microbial landscape associated with the disease to develop proper therapeutic regimens. In this literature review, recent studies are synthesized about the contribution of pathogenic bacteria to sinusitis, wherein interrelations between different microbial populations and host factors are also proposed as gaps for future research. In addition, treatment and therapeutic strategies have been also highlighted.
INTERNATIONAL JOURNAL OF HEALTH & MEDICAL RESEARCH · 2024 · 0 citations
Pathogenic Bacteria Associated with Sinusitis: A Review Article
AbstractThe sinusitis, an inflammation of paranasal sinuses, is one of the most common diseases that affect many individuals all over the world. The etiology and epidemiology of sinusitis result from complex multifactor interaction of environmental, genetic and infectious factors. Management typically involves both pharmacological and non-pharmacological means. The rationale being, sinusitis, an inflammation of the sinus cavities, is usually a disorder perpetuated by pathogenic bacteria. It is critical to have a complete understanding of the microbial landscape associated with the disease to develop proper therapeutic regimens. In this literature review, recent studies are synthesized about the contribution of pathogenic bacteria to sinusitis, wherein interrelations between different microbial populations and host factors are also proposed as gaps for future research. In addition, treatment and therapeutic strategies have been also highlighted.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
